Arvinas Inc   Report issue

For profit Phase 1
Founded: New Haven CT United States (2013)

Organization Overview

First Clinical Trial
2019
NCT03888612
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Arvinas Androgen Receptor, Inc. | Arvinas Inc